IFM Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History

IFM Investors’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.09M	Buy	38,041 +1,587	+4%	+$87.2K	0.02%	497
2025 Q1	$2.58M	Hold	36,454	–	–	0.03%	466
2024 Q4	$2.4M	Sell	36,454 -1,874	-5%	-$123K	0.02%	491
2024 Q3	$2.69M	Hold	38,328	–	–	0.03%	487
2024 Q2	$3.16M	Hold	38,328	–	–	0.03%	443
2024 Q1	$3.35M	Buy	38,328 +158	+0.4%	+$13.8K	0.04%	428
2023 Q4	$3.68M	Sell	38,170 -1,072	-3%	-$103K	0.04%	372
2023 Q3	$3.47M	Buy	39,242 +2,969	+8%	+$263K	0.05%	377
2023 Q2	$3.14M	Sell	36,273 -539	-1%	-$46.7K	0.04%	406
2023 Q1	$3.58M	Buy	36,812 +1,488	+4%	+$145K	0.05%	347
2022 Q4	$3.66M	Hold	35,324	–	–	0.06%	328
2022 Q3	$2.99M	Buy	35,324 +1,612	+5%	+$137K	0.05%	349
2022 Q2	$2.79M	Buy	33,712 +4,695	+16%	+$389K	0.05%	367
2022 Q1	$2.24M	Buy	29,017 +4,348	+18%	+$335K	0.03%	467
2021 Q4	$2.18M	Sell	24,669 -470	-2%	-$41.5K	0.04%	428
2021 Q3	$1.94M	Hold	25,139	–	–	0.04%	435
2021 Q2	$2.1M	Buy	25,139 +4,721	+23%	+$394K	0.04%	437
2021 Q1	$1.54M	Buy	20,418 +3,018	+17%	+$228K	0.04%	440
2020 Q4	$1.53M	Buy	17,400 +2,960	+20%	+$260K	0.05%	376
2020 Q3	$1.1M	Buy	14,440 +1,127	+8%	+$85.8K	0.05%	374
2020 Q2	$1.64M	Sell	13,313 -5,455	-29%	-$673K	0.08%	238
2020 Q1	$1.55M	Sell	18,768 -800	-4%	-$66K	0.07%	275
2019 Q4	$1.65M	Sell	19,568 -965	-5%	-$81.6K	0.06%	336
2019 Q3	$1.38M	Buy	20,533 +8,763	+74%	+$591K	0.05%	371
2019 Q2	$1.01M	Hold	11,770	–	–	0.06%	351
2019 Q1	$1.05M	Buy	11,770 +1,545	+15%	+$137K	0.07%	309
2018 Q4	$871K	Buy	10,225 +1,177	+13%	+$100K	0.07%	286
2018 Q3	$877K	Buy	9,048 +1,327	+17%	+$129K	0.07%	305
2018 Q2	$727K	Buy	7,721 +2,440	+46%	+$230K	0.07%	306
2018 Q1	$428K	Buy	5,281 +428	+9%	+$34.7K	0.06%	355
2017 Q4	$433K	Buy	4,853 +41	+0.9%	+$3.66K	0.07%	337
2017 Q3	$448K	Buy	4,812 +124	+3%	+$11.5K	0.08%	301
2017 Q2	$426K	Buy	4,688 +1,327	+39%	+$121K	0.08%	308
2017 Q1	$295K	Buy	+3,361	New	+$295K	0.07%	317